MA, Jun. 1 Clinical Efficacy and Serum Inflammatory Factor Level (serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) )Changes of Zoledronic Acid and Denosumab in T: serum IFCs, bone Gla protein (BGP), and bone turnover markers β-collagen degradation product (β-CTX), and procollagen type 1 N-terminal propeptide (P1NP) ). Journal of Medical Biochemistry, [S. l.], v. 44, n. 3, p. 587–594, 2025. DOI: 10.5937/jomb0-51444. Dostupno na: https://asistent.ceon.rs/index.php/jomb/article/view/51444. Pristupljeno: 12 jul. 2026.